Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara Diaz Garcia-Prada

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Methods in Cell Biology|January 29, 2023
Clonogenic assay to measure bystander cytotoxicity of targeted alpha-particle therapyJulie Constanzo, Clara Diaz Garcia-Prada, Jean-Pierre Pouget
Methods in Cell Biology|January 25, 2025
Development of an in vivo ovarian cancer peritoneal carcinomatosis model for radioimmunotherapy testingClara Diaz Garcia-Prada, Salima Atis, Jean-Pierre Pouget, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 11, 2024
Preclinical evaluation of <sup>225</sup>Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha TherapyNadine Holzleitner, Meryl Vilangattil, Abir Swaidan, et al.
ACS Pharmacology & Translational Science|July 15, 2026
Development of Radioligand Therapy-Responsive Syngeneic Prostate Models through Murine Prostate-Specific Membrane Antigen Point MutationMathis Richard, Beatrice Louis, Marco F Taddio, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2023
Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide TherapyClara Diaz Garcia-Prada, Léna Carmes, Salima Atis, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Methods in Cell Biology|January 29, 2023
Clonogenic assay to measure bystander cytotoxicity of targeted alpha-particle therapyJulie Constanzo, Clara Diaz Garcia-Prada, Jean-Pierre Pouget
Methods in Cell Biology|January 25, 2025
Development of an in vivo ovarian cancer peritoneal carcinomatosis model for radioimmunotherapy testingClara Diaz Garcia-Prada, Salima Atis, Jean-Pierre Pouget, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 11, 2024
Preclinical evaluation of <sup>225</sup>Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha TherapyNadine Holzleitner, Meryl Vilangattil, Abir Swaidan, et al.
ACS Pharmacology & Translational Science|July 15, 2026
Development of Radioligand Therapy-Responsive Syngeneic Prostate Models through Murine Prostate-Specific Membrane Antigen Point MutationMathis Richard, Beatrice Louis, Marco F Taddio, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2023
Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide TherapyClara Diaz Garcia-Prada, Léna Carmes, Salima Atis, et al.
Pageof 1